Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
VYNE Therapeutics Inc (VYNE)  
$0.22 0.00 (0.00%) as of 4:30 Fri 2/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 51,330,000
Market Cap: 11.47(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2235 - $0.2235
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   VYNE Therapeutics is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. Co.'s product candidate, FMX114, which is being evaluated for the potential treatment of mild-to-moderate atopic dermatitis. Co. is also in the preclinical stages of developing products containing Bromodomain and Extra-Terminal Domain (BET) inhibitor compounds. Co.'s initial BET inhibitor candidate in development is VYN201, an administered pan-BET inhibitor, which it is exploring in various immuno-inflammatory diseases, including skin diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 15,000 15,000 28,000
Total Buy Value $0 $43,800 $43,800 $94,578
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 186
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Domzalski David PRESIDENT AND CEO   •       •      –    2025-06-02 4 A $0.81 $7,032 D/D 8,681 454,244     -
   Harsch Mutya CHIEF LEGAL OFFICER AND GC   •       –      –    2025-06-02 4 A $0.81 $927 D/D 1,145 136,646     -
   Stuart Iain CHIEF SCIENTIFIC OFFICER   •       –      –    2025-03-31 4 D $1.58 $9,550 D/D (6,044) 122,593     -
   Zeronda Tyler CHIEF FINANCIAL OFFICER   •       –      –    2025-03-31 4 D $1.58 $13,270 D/D (8,399) 118,493     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2025-03-31 4 D $1.58 $48,187 D/D (30,498) 445,563     -
   Harsch Mutya CHIEF LEGAL OFFICER AND GC   •       –      –    2025-03-31 4 D $1.58 $13,948 D/D (8,828) 135,501     -
   Lepore Patrick G   –       •      –    2025-01-15 4 B $2.92 $43,800 D/D 15,000 51,472 0.01     -
   Zeronda Tyler CHIEF FINANCIAL OFFICER   •       –      –    2024-12-31 4 D $3.35 $15,661 D/D (4,675) 126,892     -
   Harsch Mutya CHIEF LEGAL OFFICER AND GC   •       –      –    2024-12-31 4 D $3.35 $15,735 D/D (4,697) 144,329     -
   Stuart Iain CHIEF SCIENTIFIC OFFICER   •       –      –    2024-12-31 4 D $3.35 $16,271 D/D (4,857) 128,637     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2024-12-31 4 D $3.35 $82,196 D/D (24,536) 476,061     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2024-11-30 4 A $2.10 $8,192 D/D 3,901 500,597     -
   Zeronda Tyler CHIEF FINANCIAL OFFICER   •       –      –    2024-09-30 4 D $1.88 $158 D/D (84) 131,567     -
   Harsch Mutya CHIEF LEGAL OFFICER AND GC   •       –      –    2024-09-30 4 D $1.88 $197 D/D (105) 149,026     -
   Stuart Iain CHIEF SCIENTIFIC OFFICER   •       –      –    2024-09-30 4 D $1.88 $205 D/D (109) 133,494     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2024-09-30 4 D $1.88 $1,288 D/D (685) 496,696     -
   Harsch Mutya CHIEF LEGAL OFFICER AND GC   •       –      –    2024-07-01 4 D $1.92 $275 D/D (143) 149,131     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2024-07-01 4 D $1.92 $1,795 D/D (935) 497,654     -
   Zeronda Tyler CHIEF FINANCIAL OFFICER   •       –      –    2024-07-01 4 D $1.92 $177 D/D (92) 131,651     -
   Stuart Iain CHIEF SCIENTIFIC OFFICER   •       –      –    2024-07-01 4 D $1.92 $265 D/D (138) 133,603     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2024-05-31 4 A $2.16 $9,562 D/D 4,429 498,589     -
   Stuart Iain CHIEF SCIENTIFIC OFFICER   •       –      –    2024-04-01 4 D $3.08 $484 D/D (157) 133,741     -
   Zeronda Tyler CHIEF FINANCIAL OFFICER   •       –      –    2024-04-01 4 D $3.08 $290 D/D (94) 131,743     -
   Domzalski David PRESIDENT AND CEO   •       •      –    2024-04-01 4 D $3.08 $3,092 D/D (1,004) 494,160     -
   Harsch Mutya CHIEF LEGAL OFFICER AND GC   •       –      –    2024-04-01 4 D $3.08 $496 D/D (161) 149,274     -
  186 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us